---
type: "Symbol"
title: "Contra Aeglea Biothera + (AGLE.CNT.US) — 社區討論"
description: "該股票的社區討論，包括分析師觀點、財報解讀和投資策略，來自認證金融專業人士和活躍投資者。"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/AGLE.CNT.US/topics.md"
symbol: "AGLE.CNT.US"
parent: "https://longbridge.com/zh-HK/quote/AGLE.CNT.US.md"
count: 2
datetime: "2026-03-17T06:55:46.705Z"
locales:
  - [en](https://longbridge.com/en/quote/AGLE.CNT.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AGLE.CNT.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AGLE.CNT.US/topics.md)
---

# Contra Aeglea Biothera + (AGLE.CNT.US) — 社區討論

### [I can only say I don't understand but I'm impresse…](https://longbridge.com/zh-HK/topics/38515711.md)

- 作者: [龙场悟道忘忧草](https://longbridge.com/zh-HK/profiles/14510873.md)
- 日期時間: 2026-02-05T15:17:00.000Z
- 評論: 0
- I can only say I don't understand but I'm impressed haha. The pharmaceutical industry is too far from me. I even lost a lot of money buying pharmaceutical funds before, so I can only keep my distance.

### [There are also differences between clinical phase III trials—judging the value of clinical results from academic journals](https://longbridge.com/zh-HK/topics/36273800.md)

- 作者: [济无咎](https://longbridge.com/zh-HK/profiles/9874868.md)
- 日期時間: 2025-11-12T12:39:49.000Z
- 評論: 5
- Evaluating the trial design, data quality, and clinical significance of Phase 3 clinical trials is too difficult for ordinary investors. Let professional journal editors help us evaluate. 0. Left side

**評論:**

- **扎菲特 · 2026-02-05T16:08:28.000Z · 👍 2**: Even STTT has emerged, the one submitted via WeChat? The quality of the articles inside is barely a 10, many national natural science review experts would veto this journal at first sight. The clinical research in this journal is highly questionable. Many abstracts of clinical studies were published
- **龙场悟道忘忧草 · 2026-02-05T15:17:00.000Z**: I can only say that I don't understand but I'm impressed, haha. The pharmaceutical industry is too far from me. I even lost a lot of money buying pharmaceutical funds before, so I can only keep my distance. But you're indeed professional, bro 😊
- **济无咎 · 2025-12-05T11:43:03.000Z**: Damn it, STTT's impact factor is already 53

## 參考連結

- [Contra Aeglea Biothera + (AGLE.CNT.US)](https://longbridge.com/zh-HK/quote/AGLE.CNT.US.md)


> 支持的語言: [English](https://longbridge.com/en/quote/AGLE.CNT.US/topics.md) | [简体中文](https://longbridge.com/zh-CN/quote/AGLE.CNT.US/topics.md)